Instil Bio
Hazel Jeong has a comprehensive work experience in the biotechnology industry. Hazel most recently worked as a Senior Process Engineer at Instil Bio since January 2021. Prior to that, they held various positions at Kite Pharma, including Process Engineer II from August 2020 to January 2021, Process Engineer from June 2019 to August 2020, and Cell Therapy Specialist from October 2017 to June 2019. Before joining Kite Pharma, Hazel worked as a Sr. Bioprocess Technician at Genentech from August 2013 to September 2017.
Hazel Jeong completed their Bachelor of Arts (B.A.) degree in Integrative Biology at the University of California, Berkeley from 2008 to 2012.
This person is not in any offices
Instil Bio
1 followers
Instil Bio is a cell therapy company developing tumor infiltrating lymphocytes (TIL) for the treatment of solid tumor cancers. TIL are a patient’s own T cells harvested from the patient’s tumor, which are then expanded and reinfused into the patient to target and kill cancer cells. The company is advancing its proprietary manufacturing expertise, technology, and data into clinical trials, including a planned registrational study with its lead candidate and a first-in-human study of its next-generation engineered TIL. The company is led by world-class cell therapy experts and backed by premier global institutional investors. Instil is located in the greater Los Angeles area with additional manufacturing and research facilities in Manchester, UK.